DigiCon

How many patients of asthma do you see every month in your practice approximately?

1-10

11-30

31-50

More than 50

What is the relative percentage of disease severity amongst the patients of asthma? *

	Percentage
Mild	%
Mild to moderate	%
Moderate to severe	%
Severe	%

What are the most common symptoms that patients with asthma present in your practice? *

Symptoms	Tick all applicable
Cough
Chest Tightness
Mucus secretion
Breathlessness
Mention if any other

What are the cardinal signs you observe in your asthma patients? *

Signs	Tick all applicable
Sputum production
Wheezing
Increased respiratory rate
Dyspnea

What are the most common diagnostic investigations you perform in your practice? *

	Tick all applicable
Chest X-ray
Pulmonary Function Test (PFT)
Complete blood count for serum eosinophils
Allergen testing
HRCT
High resolution compounded tomography
FeNO
Mention if any other

Which are the most common comorbidities you observe associated with asthma in your practice? *

Comorbidity	Percentage of patients
	%
	%
	%
	%

What is the duration of follow-up visits of patients of asthma in your practice? *

	Kindly mention duration in weeks
Mild
Mild to moderate
Moderate to severe
Severe

Which is your preferred therapy choice for various asthma severity? *

	ICS, ICS + LABA, ICS+LABA+LAMA	Formulation Nebulization/Inhaler	Duration of therapy
Mild
Mild to moderate
Moderate to severe
Severe

What are the factors determining your choice of ICS+LABA combination? *

	Tick all applicable
Efficacy
Quick onset of action
Duration of action
Convenient dosing for patient adherence

Which is the preferred choice of ICS+LABA combination as per GINA categories of patients in your practice? *

GINA	Preferred ICS+LABA combination
Step 1
Step 2
Step 3
Step 4
Step 5

Which is the preferred ICS+LABA combination as per ACT score? *

	Preferred ICS+LABA combination
More than 20
16-19
<15

Which ICS+LABA combination do you prefer in your practice as maintenance/controller of asthma symptoms? *

ICS+LABA Combination	Dosage Form (MDI/DPI/NEB)	Duration of therapy in weeks
Formoterol + Budesonide
Vilanterol + Fluticasone Furoate
Salmeterol + Fluticasone Propionate
Formoterol +Fluticasone Propionate
Indacaterol + Mometasone

Which is the preferred reliever with ICS+LABA combination? *

ICS+LABA Combination	Preferred Reliever
Formoterol + Budesonide
Vilanterol + Fluticasone Furoate
Salmeterol + Fluticasone Propionate
Formoterol +Fluticasone Propionate
Indacaterol + Mometasone

Do you prefer switching patients of controlled asthma from BD ICS+LABA to OD ICS+uLABA? *

Yes

No

Sometimes

If Yes, do you see improved patient compliance while switching to OD dosing?

Yes

No

Sometimes

{{--

-

--}}

Which type of patients do you prefer combination therapy of VI+FF? *

	Percentage	Dose 100 or 200
Mild	%	{{-- --}}
Mild to moderate	%	{{-- --}}
Moderate to severe	%	{{-- --}}
Severe	%	{{-- --}}

VI+FF is a preferred combination in which category of patients? *

New patients

Existing patients on BID ICS+LABA

Both

VI+FF is a preferred choice in which of the following patient profiles in your practice? *

	Tick wherever applicable
Maintenance therapy for controlled patients
Patient with exacerbations

What makes VI+FF a preferred choice over other BID ICS+LABA? *

Do you feel OD dosing of VI+FF improves patient adherence in your practice? *

Yes

No

Sometimes

In your practice, what is the percentage of patients who have been switched from BID ICS+LABA to OD ICS+LABA? *

Do you prefer VI+FF in patients with cardiovascular comorbidity or high risk for cardiac diseases? *

Yes

No

Sometimes

Please mention any unmet medical need that may improve patient outcome in patients with asthma *

{{ $ActivityTypeName }}

Survey Questionnaire

An observational cross-sectional survey to understand the management paradigm of bronchial asthma and role of various combination therapies of fixed-dose inhaled corticosteroids (ICS) and long acting ẞ2 agonist (LABA) in Indian settings

Questionnaire